nach oben

Journal of Neuro-Oncology

Erschienen in:

31.10.2018 | Clinical Study

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The immune system plays an important role in cancer survival and disease progression, but the role of the immune system in lower grade glioma (LGG) is largely unknown

Methods

To investigate the relationship between lymphocyte infiltration into the LGG microenvironment and LGG survival, we used a genomics approach to recover productive V(D)J recombination sequences from primary tumor, whole exome sequence files available via the cancer genome atlas

Results

Increased T-cell receptor V(D)J read recovery, indicating increased T-lymphocyte infiltration into the primary tumor site, strongly correlated with decreased overall and disease-free survival; and with a more advanced cancer grade. In addition, this result was more significant than related results obtainable using RNASeq-based, T-cell biomarkers, similar to a recently reported case for pancreatic cancer, where the recovery of BCR recombination reads from WXS files clearly associated with reduced survival, despite the fact that no such association was demonstrable with B-cell based, RNASeq biomarkers

Conclusions

Overall, the results presented here support V(D)J recombination read recovery, from whole exome files, as a uniquely useful biomarker for distinct LGG survival rates.

Nur mit Berechtigung zugänglich

de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411–423. https://doi.org/10.1016/j.ccr.2005.04.014 CrossRefPubMed

Parrish RA, Karsten MB, McRae AT, Moretz WH (1968) Segmental Crohn’s colitis associated with adenocarcinoma. Am J Surg 115:371–375CrossRefPubMed

Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444. https://doi.org/10.1038/nature07205 CrossRefPubMed

Callahan BM, Yavorski JM, Tu YN, Tong WL, Kinskey JC, Clark KR, Fawcett TJ, Blanck G (2018) T-cell receptor-beta V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer Immunol Immunother 67:885–892. https://doi.org/10.1007/s00262-018-2139-7 CrossRefPubMed

Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A (2014) Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer 110:2560–2568. https://doi.org/10.1038/bjc.2014.162 CrossRefPubMedPubMedCentral

Samy MD, Tong WL, Yavorski JM, Sexton WJ, Blanck G (2017) T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer. Cancer Immunol Immunother 66:403–410. https://doi.org/10.1007/s00262-016-1943-1 CrossRefPubMed

Disis ML (2010) Immune regulation of cancer. J Clin Oncol 28:4531–4538. https://doi.org/10.1200/JCO.2009.27.2146 CrossRefPubMedPubMedCentral

Szekeres K, Koul R, Mauro J, Lloyd M, Johnson J, Blanck G (2014) An Oct-1-based, feed-forward mechanism of apoptosis inhibited by co-culture with Raji B-cells: towards a model of the cancer cell/B-cell microenvironment. Exp Mol Pathol 97:585–589. https://doi.org/10.1016/j.yexmp.2014.09.010 CrossRefPubMedPubMedCentral

Wang K, Liu J, Li J (2018) IL-35-producing B cells in gastric cancer patients. Medicine (Baltimore) 97:e0710. https://doi.org/10.1097/MD.0000000000010710 CrossRef

10.

Kinskey JC, Tu YN, Tong WL, Yavorski JM, Blanck G (2018) Recovery of immunoglobulin VJ recombinations from pancreatic cancer exome files strongly correlates with reduced survival. Cancer Microenviron 11:51–59. https://doi.org/10.1007/s12307-018-0205-5 CrossRefPubMedPubMedCentral

11.

Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G (2016) Detection of productively rearranged TcR-alpha V-J sequences in TCGA exome files: implications for tumor immunoscoring and recovery of antitumor T-cells. Cancer Inform 15:23–28. https://doi.org/10.4137/CIN.S35784 CrossRefPubMedPubMedCentral

12.

Levy E, Marty R, Garate Calderon V, Woo B, Dow M, Armisen R, Carter H, Harismendy O (2016) Immune DNA signature of T-cell infiltration in breast tumor exomes. Sci Rep 6:30064. https://doi.org/10.1038/srep30064 CrossRefPubMedPubMedCentral

13.

Brown SD, Raeburn LA, Holt RA (2015) Profiling tissue-resident T cell repertoires by RNA sequencing. Genome Med 7:125. https://doi.org/10.1186/s13073-015-0248-x CrossRefPubMedPubMedCentral

14.

Li B, Li T, Pignon JC, Wang B, Wang J, Shukla SA, Dou R, Chen Q, Hodi FS, Choueiri TK, Wu C, Hacohen N, Signoretti S, Liu JS, Liu XS (2016) Landscape of tumor-infiltrating T cell repertoire of human cancers. Nature Genet 48:725–732. https://doi.org/10.1038/ng.3581 CrossRefPubMed

15.

Tu YN, Tong WL, Samy MD, Yavorski JM, Kim M, Blanck G (2017) Assessing microenvironment immunogenicity using tumor specimen exomes: co-detection of TcR-alpha/beta V(D)J recombinations correlates with PD-1 expression. Int J Cancer 140:2568–2576. https://doi.org/10.1002/ijc.30675 CrossRefPubMed

16.

Mai AT, Tong WL, Tu YN, Blanck G (2018) TcR-alpha recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers. Int Immunol 30:35–40. https://doi.org/10.1093/intimm/dxx074 CrossRefPubMedPubMedCentral

17.

Tu YN, Tong WL, Yavorski JM, Blanck G (2018) Immunogenomics: a negative prostate cancer outcome associated with TcR-gamma/delta recombinations. Cancer Microenviron 11:41–49. https://doi.org/10.1007/s12307-018-0204-6 CrossRefPubMedPubMedCentral

18.

Ping Z, Siegal GP, Almeida JS, Schnitt SJ, Shen D (2014) Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology. J Pathol Inform 5:3. https://doi.org/10.4103/2153-3539.126147 CrossRefPubMedPubMedCentral

19.

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. https://doi.org/10.1126/scisignal.2004088 CrossRefPubMedPubMedCentral

20.

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095 CrossRefPubMed

21.

Kioussis D, Ellmeier W (2002) Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nature Rev Immunol 2:909–919. https://doi.org/10.1038/nri952 CrossRef

22.

Tai Y, Wang Q, Korner H, Zhang L, Wei W (2018) Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases. Front Pharmacol 9:642. https://doi.org/10.3389/fphar.2018.00642 CrossRefPubMedPubMedCentral

23.

Maxwell R, Jackson CM, Lim M (2017) Clinical trials investigating immune checkpoint blockade in glioblastoma. Curr Treat Options Oncol 18:51. https://doi.org/10.1007/s11864-017-0492-y CrossRefPubMed

24.

Edwards KM, Davis JE, Browne KA, Sutton VR, Trapani JA (1999) Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction. Immunol Cell Biol 77:76–89. https://doi.org/10.1046/j.1440-1711.1999.00799.x CrossRefPubMed

25.

Huang Y, de Leval L, Gaulard P (2013) Molecular underpinning of extranodal NK/T-cell lymphoma. Best Pract Res Clin Haematol 26:57–74. https://doi.org/10.1016/j.beha.2013.04.006 CrossRefPubMed

26.

Marcucci F, Rumio C, Corti A (2017) Tumor cell-associated immune checkpoint molecules—drivers of malignancy and stemness. Biochim Biophys Acta 1868:571–583. https://doi.org/10.1016/j.bbcan.2017.10.006 CrossRef

27.

Reck M (2018) Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer. Immunotherapy 10:93–105. https://doi.org/10.2217/imt-2017-0121 CrossRefPubMed

28.

Nagarajan UM, Bushey A, Boss JM (2002) Modulation of gene expression by the MHC class II transactivator. J Immunol 169:5078–5088CrossRefPubMed

29.

Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, Signoretti S, Liu JS, Liu XS (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17:174. https://doi.org/10.1186/s13059-016-1028-7 CrossRefPubMedPubMedCentral

30.

Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Gyorffy B, Brastianos PK, Binder DC, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA (2017) Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival. Clin Cancer Res 23:6650–6660. https://doi.org/10.1158/1078-0432.CCR-17-0120 CrossRefPubMedPubMedCentral

31.

Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Blanck G (2018) Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme. Biochem Biophys Res Commun. https://doi.org/10.1016/j.bbrc.2018.06.141 CrossRefPubMed

32.

Sims JS, Grinshpun B, Feng Y, Ung TH, Neira JA, Samanamud JL, Canoll P, Shen Y, Sims PA, Bruce JN (2016) Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire. Proc Natl Acad Sci USA 113:E3529–E3537. https://doi.org/10.1073/pnas.1601012113 CrossRefPubMedPubMedCentral

33.

Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T (1993) Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53:3569–3573PubMed

34.

Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27:407–414. https://doi.org/10.1002/hep.510270214 CrossRefPubMed

35.

Anitei MG, Zeitoun G, Mlecnik B, Marliot F, Haicheur N, Todosi AM, Kirilovsky A, Lagorce C, Bindea G, Ferariu D, Danciu M, Bruneval P, Scripcariu V, Chevallier JM, Zinzindohoue F, Berger A, Galon J, Pages F (2014) Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res 20:1891–1899. https://doi.org/10.1158/1078-0432.CCR-13-2830 CrossRefPubMed

36.

Shibuya TY, Nugyen N, McLaren CE, Li KT, Wei WZ, Kim S, Yoo GH, Rogowski A, Ensley J, Sakr W (2002) Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 8:745–751PubMed

Titel: Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade
Publikationsdatum: 31.10.2018
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2018
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-018-03001-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience

Diagnostic accuracy of MRI texture analysis for grading gliomas

Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review